Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ADDONIS: Vildagliptin vs SU with Basal Insulin in T2DM
NCT01871558Phase 3Completed
- Sponsor
- Novartis
- Start
- Jun 2013
- Primary completion
- Feb 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of vildagliptin in type 2 diabetes mellitus (T2DM), sponsored by Novartis. Started Jun 2013; status: completed.
02
Drugs
vildagliptin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT01871558.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01871558.